Selected Publications
Ofer Margalit; Einat Shacham-Shmueli; Yu-Xiao Yang; Yaacov R. Lawerence; Kim A. Reiss; Talia Golan; Naama Halpern; Dan Aderka; Bruce Giantonio ; Ronac Mamtani; and Ben Boursi: Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma The Oncologist : 2021.
Zain Hannan, BA; Shun Yu, MD; Susan Domchek, MD; Ronac Mamtani, MD; Kim A. Reiss, MD: Clinical Characteristics of Patients with Pancreatic Cancer and Pathogenic ATM Alterations JNCI Cancer Spectrum : 2021.
Shun Yu, MD; Ronac Mamtani, MD, MSCE1; Mark H. O’Hara, MD; Peter J. O’Dwyer, MD; Ofer Margalit, MD; Bruce J. Giantonio, MD; Einat Shmueli, MD, Kim A. Reiss, MD* and Ben Boursi, MD1*, *Authors contributed equally: Comparative effectiveness of total neoadjuvant therapy versus standard adjuvant chemotherapy for locally advanced rectal cancer Clinical Colorectal Cancer : 2021.
Kim A. Reiss1; Max M. Wattenberg; Nevena Damjanov; Elizabeth P. Dunphy; Mona Jacobs-Small; M. Judy Lubas; James Robinson; Lisa Dicicco; Luis Garcia-Marcano; Michael A. Giannone;Thomas Karasic; Emma E. Furth; Erica Carpenter; Andrzej Wojcieszynski; Robert H. Vonderheide; Gregory L. Beatty; Edgar Ben-Josef: A Pilot Study of Galunisertib Plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma Mol Cancer Ther
: 2020.
Erin M. Bange MD, Abigail Doucette MPH, Peter E. Gabriel. MD MS, Florence Porterfield, James J. Harrigan MD PharmD, Robin Wang, Andrez P. Wojcieszynski MD, Ben Boursi MD, 2, Bethany I. Mooney CRNP, Kim A. Reiss, MD*, Ronac Mamtani MD MSCE*: Opportunity costs of receiving palliative chemotherapy for metastatic pancreatic ductal adenocarcinoma JCO Oncol Pract
16 (8): e678-e687,2020.
Takahiro Tsujikawa, Todd Crocenzi, Jennifer Durham, Elizabeth Sugar, Annie Wu, Beth Onners, Julie Nauroth, Robert Anders, Elana Fertig, Daniel Laheru, Kim Reiss, Robert Vonderheide, Andrew Ko, Margaret Tempero, George Fisher, Michael Considine, Ludmila Danilova, Dirk Brockstedt, Lisa Coussens, Elizabeth Jaffee, and Dung Le: Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer Clin Cancer Res
26 (14): 3578-3588. ,2020.
Max M. Wattenberg; Kim A. Reiss; Rosemarie Mick; Michael Giannone; Nevena Damjanov; Elizabeth P. Dunphy; Lisa Dicicco; Luis Garcia-Marcano; Thomas Karasic; Emma E. Furth; Andrzej Wojcieszynski; Robert, H. Vonderheide; Edgar Ben-Josef; Gregory L. Beatty: Peripheral blood immune correlates associated with TGF-β inhibition (galunisertib) and stereotactic body radiotherapy (SBRT) in patients with advanced hepatocellular carcinoma (HCC). ASCO Annual Meeting, Chicago, IL (remote due to COVID-19) : 2020.
Akram Saad, Jeffrey Goldstein, Ofer Margalit, Einat Schacham-Shmueli, Yaacov R. Lawrence, Yu-Xiao Yang, Kim A. Reiss, Talia Golan, Ronac Mamtani, Naama Halpern, Dan Aderka, Meir Mouallem, Adam Goldstein, Bruce Giantonio, Ben Boursi: Assessing the effects of beta blockers on pancreatic cancer risk: A nested case control study Pharmacoepidemiol Drug Saf
29 (5): 599-604,2020.
Kim Reiss Binder: When Isolation is Worse Than Death: Philly oncologist on cancer patients and COVID-19 - Opinion Philadelphia Inquirer : 2020.
Max Wattenberg, Daniella Asch, Shun Yu, Peter O’Dwyer, Susan Domchek, Katherine Nathanson, Mark Rosen, Gregory L Beatty, Evan Siegelman, and Kim Reiss: Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation Br J Cancer
122 (3): 333-339,2020.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia,
PA
19104
Phone: 215-360-0735
Patient appointments: 800-789-7366